686210login-checkTrial Affirms Safety of Circulatory-Death Heart Transplants |
— 6-month results reported for perfusion-tested hearts outside of normal brain-death donation route
By Crystal Phend
Transplants from circulatory-death donor hearts assessed with a perfusion machine did just as well as those procured after brain death and cold storage, a randomized trial showed.
Recipients of a circulatory-death heart had noninferior risk-adjusted 6-month survival compared with brain-death heart recipients (94% vs 90%) in the as-treated population, with a 3-percentage point advantage by the least-squares mean difference calculation in the primary endpoint (P<0.001 for noninferiority). Read the full article in MedPage Today.
686210login-checkTrial Affirms Safety of Circulatory-Death Heart Transplants |